Glucose monitoring devices in type 1 diabetes

There are many different types of glucose monitors or meters for monitoring your blood glucose, with various different features. Some devices may suit your needs better than others. Some features to consider include:

  • the size and weight of the device
  • screen size and how the instructions and results are displayed on the screen
  • the time the test takes (devices vary, taking from 4 seconds up to 10 seconds)
  • how the device stores your results (e.g. as a trend in your blood glucose levels or as pre- and post-meal average readings).

Glucose monitors or meters can be bought from pharmacies, diabetes centres and from Diabetes Australia. Your doctor or a diabetes educator can help you choose the meter that’s best for you. Your doctor or diabetes educator can also show you how to use your meter correctly, so that your readings are as accurate as possible.

Register with the National Diabetes Services Scheme

The National Diabetes Services Scheme (NDSS) can provide diabetes-related blood glucose monitoring equipment at subsidised prices, and provides information and support on a range of topics. Registration is free. Ring them on 1300 136 588 or visit www.ndss.com.au.

References
  • Craig ME, Twigg SM, Donaghue KC, et al for the Australian Type 1 Diabetes Guidelines Expert Advisory Group. National evidence-based clinical care guidelines for type 1 diabetes in children, adolescents and adults. Canberra: Australian Government Department of Health and Ageing, 2011. www.diabetessociety.com.au/downloads/ Type1guidelines14Nov2011.pdf (accessed 15 November 2011).
  • Type 2 diabetes: priorities and targets. NPS NEWS (www.nps.org.au/health_professionals/publications/nps_news/current/type_2_diabetes_priorities_targets)
  • Yudkin JS, Richter B, Gale EA. Intensified glucose lowering in type 2 diabetes: time for a reappraisal. Diabetologia 2010;53:2079–85.
  • Turnbull FM, Abraira C, Anderson RJ, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009;52:2288–98.
  • Kearney PM, Blackwell L, Collins R, et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008;371:117–25.
  • Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665.